Tevogen Bio Holdings (TVGN) EBITDA (2023 - 2026)
Tevogen Bio Holdings (TVGN) reported EBITDA of -$5.4 million for Q1 2026, up 47.85% on a YoY basis from -$3.7 million in Q1 2025, and down 17.15% quarter-over-quarter from -$4.6 million in Q4 2025.
Tevogen Bio Holdings (TVGN) EBITDA (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported EBITDA for 4 years, with the latest figure at -$5.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 47.85% year-over-year to -$5.4 million; the trailing twelve-month figure through Mar 2026 stood at -$21.2 million (up 38.42% YoY), and the FY2025 full-year result was -$26.1 million, up 51.2% from the prior year.
- EBITDA for Q1 2026 stood at -$5.4 million, down from -$4.6 million in the prior quarter.
- The five-year high for EBITDA was -$2.0 million in Q4 2023, with the low at -$29.5 million in Q1 2024.
- Historically, EBITDA has averaged -$7.2 million across 4 years, with a median of -$5.4 million in 2025.
- Annual changes were most pronounced in 2024 — EBITDA sank 1169.93% — and 2025, when it surged 64.91%.
- Tevogen Bio Holdings' EBITDA stood at -$2.0 million in 2023, then sank by 366.0% to -$9.4 million in 2024, then surged by 50.76% to -$4.6 million in 2025, then slipped by 17.15% to -$5.4 million in 2026.
- The last three EBITDA figures came in at -$5.4 million (Q1 2026), -$4.6 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.40 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -5.73 Mn |
| Jun 30, 2025 | -5.44 Mn |
| Mar 31, 2025 | -10.36 Mn |
| Dec 31, 2024 | -9.36 Mn |
| Sep 30, 2024 | -6.09 Mn |
| Jun 30, 2024 | -8.60 Mn |
| Mar 31, 2024 | -29.52 Mn |
| Dec 31, 2023 | -2.01 Mn |
| Sep 30, 2023 | -2.33 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -2.32 Mn |